טוען...
Trends in prostate cancer incidence and mortality in Canada during the era of prostate-specific antigen screening
BACKGROUND: Widespread use of prostate-specific antigen (PSA) to screen for prostate cancer began in the early 1990s. Advocates for screening assert that this has caused a decrease in prostate cancer mortality. We sought to describe secular changes in prostate cancer incidence and mortality in Canad...
שמור ב:
| הוצא לאור ב: | CMAJ Open |
|---|---|
| Main Authors: | , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
8872147 Canada Inc.
2016
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4866930/ https://ncbi.nlm.nih.gov/pubmed/27280117 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.9778/cmajo.20140079 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|